Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Adenosine Regulation of cAMP through Phosphodiesterases

Bunyan Teng, PhD, Daniel N Darlington, PhD, Andrew P Cap, MD PhD

Blood (2018) 132 (Supplement 1): 2424.

https://doi.org/10.1182/blood-2018-99-114929

Published: 2018

Journal Articles

Plasmodium falciparum STEVOR phosphorylation regulates host erythrocyte deformability enabling malaria parasite transmission

Bernina Naissant, Florian Dupuy, Yoann Duffier, Audrey Lorthiois, Julien Duez, Judith Scholz, Pierre Buffet, Anais Merckx, Anna Bachmann, Catherine Lavazec

Blood (2016) 127 (24): e42–e53.

https://doi.org/10.1182/blood-2016-01-690776

Published: 2016

Includes: Supplemental data

Journal Articles

An Integrative Network Approach for Genomic Discovery and Personalized Therapy in Relapsed Multiple Myeloma

Ben Readhead, MBBS, Krishan Kania, Caroline Eden, Deepak Perumal, PhD, Vickram Gidwani, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Sundar Jagannath, MD, Pei-Yu Kuo, MS, Brian Kidd, PhD, Joel Dudley, PhD, Samir Parekh

Blood (2014) 124 (21): 3426.

https://doi.org/10.1182/blood.V124.21.3426.3426

Published: 2014

Journal Articles

Assessment Of a Novel Synthetic Collagen Reagent By Platelet Aggregometry

Walter Jeske, PhD, Vicki Escalante, BS, Jeanine M. Walenga, PhD, Mamdouh Bakhos, MD

Blood (2013) 122 (21): 3645.

https://doi.org/10.1182/blood.V122.21.3645.3645

Published: 2013

Journal Articles

Parathyroid Hormone-Induced Modulation of the Bone Marrow Microenvironment Inhibits the Development of Murine Chronic Myelogenous-Leukemia-Like Disease

Daniela S. Krause, MD, PhD, Sanon Lezeau, Michael Hurley, Ernestina Schipani, MD, David T. Scadden, MD

Blood (2010) 116 (21): 937.

https://doi.org/10.1182/blood.V116.21.937.937

Published: 2010

Journal Articles

Want fries with that? Antimyeloma drug combos

Aaron D. Schimmer

Blood (2010) 116 (4): 510–511.

https://doi.org/10.1182/blood-2010-04-279927

Published: 2010

Journal Articles

Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies

Richard J. Rickles, Laura T. Pierce, Thomas P. Giordano, 3rd, Winnie F. Tam, Douglas W. McMillin, Jake Delmore, Jacob P. Laubach, Alexis A. Borisy, Paul G. Richardson, Margaret S. Lee

Blood (2010) 116 (4): 593–602.

https://doi.org/10.1182/blood-2009-11-252668

Published: 2010

Includes: Supplemental data

Journal Articles

Adenosine A2A Receptor Agonism and PDE Inhibition: A Synergistic Multi-Target Mechanism Discovered through Systematic Combination Screening in Multiple Myeloma

Richard J Rickles, Ph.D., Laura Pierce, Thomas Giordano, Winnie F. Tam, Ph.D., Douglas W. McMillin, BSc, PhD, Kenneth C. Anderson, MD, Constantine Mitsiades, M.D., Ph.D., Margaret S Lee, Ph.D

Blood (2008) 112 (11): 847.

https://doi.org/10.1182/blood.V112.11.847.847

Published: 2008

Journal Articles

Cytotoxicity of the Type 4 Phosphodiesterase Inhibitor CD160130 for Freshly Isolated Human CLL Cells In Vitro.

J. Brice Weinberg, MD, Ning Jiang, MD, Alicia D. Volkheimer, MS, Youwei Chen, MD, Karen M. Bond, BS, Joseph O. Moore, MD, Jon P. Gockerman, MD, Louis F. Diehl, MD, Carlos M. de Castro, MD, David A. Rizzieri, MD, PhD, Marc C. Levesque, MD, PhD, Kenneth Mugridge, PhD, Joe DeAngelo

Blood (2007) 110 (11): 3129.

https://doi.org/10.1182/blood.V110.11.3129.3129

Published: 2007

Journal Articles

Rexinoid-Triggered Differentiation and Tumor-Selective Apoptosis of AML by Protein Kinase A-Mediated De-Subordination.

Ettore Mariano Schiavone, MD, Lucia Altucci, MD, Mariacarla De Simone, MD, Felicetto Ferrara, MD, Aurélie Rossin, Fellow, Oliver Hirsch, Fellow, Angela Nebbioso, Fellow, Dominique Vitoux, MD, Emmanuelle Wilhelm, Fellow, Fabien Guidez, PhD, Arthur Zelent, MD, David Grimwade, MD, Hugues de Thé, MD, Hinrich Gronemeyer, PhD

Blood (2006) 108 (11): 2235.

https://doi.org/10.1182/blood.V108.11.2235.2235

Published: 2006

Journal Articles

Follow-Up of Clinical Manifestations and Platelet Function Test in Patients with Essential Thrombocythemia on Anagrelide Treatment.

Patricia S. Vassallu, MD, Nora P. Goette, Ana C. Glembotsky, Paula G. Heller, MD, Laura I. Kornblihtt, Ph.D, Paola R. Lev, Ph.D, Daniel C. Chazarreta, Juan P. Salim, Maria S. Laguna, Rosana F. Marta, Ph.D, Felisa C. Molinas, Ph.D.

Blood (2005) 106 (11): 4970.

https://doi.org/10.1182/blood.V106.11.4970.4970

Published: 2005

Journal Articles

Clinical Responses to Sildenafil in Waldenstrom’s Macroglobulinemia.

Steven P. Treon, Olivier Tournilhac, Andrew Branagan, Zachary Hunter, Lian Xu, Evdoxia Hatjiharissi, Daniel Ditzel Santos

Blood (2004) 104 (11): 4926.

https://doi.org/10.1182/blood.V104.11.4926.4926

Published: 2004

Journal Articles

Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells

Marika Sarfati, Véronique Mateo, Sylvie Baudet, Manuel Rubio, Christine Fernandez, Fréderic Davi, Jacques-Louis Binet, Jozo Delic, Hélène Merle-Béral

Blood (2003) 101 (1): 265–269.

https://doi.org/10.1182/blood-2002-01-0075

Published: 2003

Journal Articles

Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21 WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells

Ryosuke Ogawa, Michael B. Streiff, Artem Bugayenko, Gregory J. Kato

Blood (2002) 99 (9): 3390–3397.

https://doi.org/10.1182/blood.V99.9.3390

Published: 2002

Journal Articles

Type 4 Cyclic Adenosine Monophosphate Phosphodiesterase as a Therapeutic Target in Chronic Lymphocytic Leukemia

Doo Ho Kim, Adam Lerner

Blood (1998) 92 (7): 2484–2494.

https://doi.org/10.1182/blood.V92.7.2484

Published: 1998

NARROW

Adenosine Regulation of cAMP through Phosphodiesterases

Plasmodium falciparum STEVOR phosphorylation regulates host erythrocyte deformability enabling malaria parasite transmission

An Integrative Network Approach for Genomic Discovery and Personalized Therapy in Relapsed Multiple Myeloma

Assessment Of a Novel Synthetic Collagen Reagent By Platelet Aggregometry

Parathyroid Hormone-Induced Modulation of the Bone Marrow Microenvironment Inhibits the Development of Murine Chronic Myelogenous-Leukemia-Like Disease

Want fries with that? Antimyeloma drug combos

Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies

Adenosine A2A Receptor Agonism and PDE Inhibition: A Synergistic Multi-Target Mechanism Discovered through Systematic Combination Screening in Multiple Myeloma

Cytotoxicity of the Type 4 Phosphodiesterase Inhibitor CD160130 for Freshly Isolated Human CLL Cells In Vitro.

Rexinoid-Triggered Differentiation and Tumor-Selective Apoptosis of AML by Protein Kinase A-Mediated De-Subordination.

Follow-Up of Clinical Manifestations and Platelet Function Test in Patients with Essential Thrombocythemia on Anagrelide Treatment.

Clinical Responses to Sildenafil in Waldenstrom’s Macroglobulinemia.

Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells

Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21 WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells

Type 4 Cyclic Adenosine Monophosphate Phosphodiesterase as a Therapeutic Target in Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only